Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

(2016) Ludwig Kappos et al.   Multiple Sclerosis Journal

Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis

(2015) Shahamat Tauhid et al.   JOURNAL OF NEUROLOGY

Cognitive impairment and memory disorders in relapsing–remitting multiple sclerosis: the role of white matter, gray matter and hippocampus

(2015) R. Sacco et al.   JOURNAL OF NEUROLOGY

Fingolimod effect on brain volume loss independently contributes to its effect on disability

(2015) MP Sormani et al.   Multiple Sclerosis Journal

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

(2015) E.-W. Radue et al.   NEUROLOGY

Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial

(2015) L. Kappos et al.   NEUROLOGY

Fingolimod effect on brain volume loss independently contributes to its effect on disability

(2015) MP Sormani et al.   Multiple Sclerosis Journal

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study

(2014) Cecilie Jacobsen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

(2013) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Cognitive Reserve and Symptom Experience in Multiple Sclerosis: A Buffer to Disability Progression Over Time?

(2013) Carolyn E. Schwartz et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Brain atrophy and lesion load predict long term disability in multiple sclerosis

(2013) Veronica Popescu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study

(2013) M. P. Amato et al.   NEUROLOGY

Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it

(2013) J. F. Sumowski et al.   NEUROLOGY

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

A longitudinal study of brain volume changes in normal aging

(2011) Hidemasa Takao et al.   EUROPEAN JOURNAL OF RADIOLOGY

Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies

(2011) Anna M. Hedman et al.   HUMAN BRAIN MAPPING

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

(2009) E. M. Mowry et al.   NEUROLOGY

Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates

(2008) A SIDAROS et al.   NEUROIMAGE